INCY

Incyte Corporation (INCY)

Last Price$70.5(3.7%)
Market Cap$13.5B
LTM FCF to Net Income
51.7%
5Y avg
98.4%
Biotechnology industry median
83.9%
Stock quality & Intrinsic value
5/10
0.1% undervalued

Incyte Corporation FCF to Net Income

Annual
Quarterly
LTM
Industry median
Company stand-alone
INCY
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
FCF to Net Income
70.4%
100.4%
70.0%
108.0%
79.1%
(5.7%)
(294.6%)
88.7%
220.4%
(5.9%)
3.3%
926.9%
177.0%
65.1%
240.0%
141.5%
105.5%
59.9%
261.9%
75.1%
INCY
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for INCY and see if it's the right time to invest.
Dive in

Incyte Corporation (INCY) FCF to Net Income comparison analysis

Crunching data... Almost there!

INCY key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Incyte Corporation's FCF to Net Income?

As of today, Microsoft Corp's last 12-month FCF to Net Income is 51.7%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual FCF to Net Income for Incyte Corporation have been 98.6% over the past three years, and 103.3% over the past five years.

2) Is Incyte Corporation's FCF to Net Income Good?

As of today, Incyte Corporation's FCF to Net Income is 51.7%, which is lower than industry median of 83.9%. It indicates that Incyte Corporation's FCF to Net Income is Bad.

3) How does Incyte Corporation's FCF to Net Income compare to its peers?

As of today, Incyte Corporation's FCF to Net Income is 51.7%, which is lower than peer median of 92.0%. The list of peers includes VRTX, MRNA, GMAB, BGNE, ARGX, UTHR, REGN, NVO, ALNY, BNTX.